Financials data is unavailable for this security.
View more
Year on year Aequus Pharmaceuticals Inc had revenues fall -81.53% from 1.38m to 254.90k, though the company grew net income from a loss of 3.21m to a smaller loss of 2.96m.
Gross margin | 53.31% |
---|---|
Net profit margin | -1,029.67% |
Operating margin | -1,044.66% |
Return on assets | -302.43% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in CADView more
In 2023, cash reserves at Aequus Pharmaceuticals Inc fell by 79.62k. Cash Flow from Financing totalled 2.21m or 868.72% of revenues. In addition the company used 2.29m for operations while cash used for investing totalled .
Cash flow per share | -0.0206 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0423 |
---|---|
Tangible book value per share | -0.0423 |
More ▼
Balance sheet in CADView more
Current ratio | 0.0697 |
---|---|
Quick ratio | 0.0431 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 10.65 |
More ▼